AI-generated summary
In a mouse model of ovalbumin-induced allergic asthma, the authors studied a pulsed 980 nm near-infrared laser treatment. They report that the treatment reduced airway thickening and inflammatory cell infiltration in lung tissue, lowered type 2 cytokine gene expression, and reduced eosinophil and monocyte infiltration. The study was conducted in mice, so its relevance to human asthma is not established.
- Who or what was studied
- Mice with ovalbumin-induced allergic asthma
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The study was conducted in a murine model, so findings may not translate to human asthma.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on nature.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.